"Wir sind eine Praxis, die auf die Diagnostik und Therapie von hämatologisch-onkologischen Erkrankungen spezialisiert ist. Im Einzelnen umfasst unser Betreuungsspektrum Bluterkrankungen, bösartige Tumorerkrankungen, Betreuung nach Knochenmarktransplantation, Tumornachsorge von Patienten nach Operationen, Chemotherapie und Bestrahlung. Wir beraten Sie bei allen onkologischen Fragestellungen. Unsere Schwerpunktpraxis nimmt an nationalen und internationalen Therapiestudien teil."

During the past decade, Onkologische Gemeinschaftspraxis conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 9 clinical trials were completed, i.e. on average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Onkologische Gemeinschaftspraxis" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "German CLL Study Group" with 3 trials sponsored, "HiberCell, Inc." with 1 trials sponsored, "Institut de Recherches Internationales Servier" with 1 trials sponsored and "Ludwig-Maximilians - University of Munich" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Onkologische Gemeinschaftspraxis" #1 collaborator was "Cancer Trials Ireland" with 2 trials as a collaborator, "Nordic CLL Study Group (NCLLSG)" with 2 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Onkologische Gemeinschaftspraxis" are "Colorectal Cancer" (3 trials), "Non-Hodgkin's Lymphoma" (3 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Chronic Lymphoid Leukemia" (2 trials) and "Advanced Colorectal Carcinoma" (1 trials). Many other conditions were trialed in "Onkologische Gemeinschaftspraxis" in a lesser frequency.

Most popular intervention types in "Onkologische Gemeinschaftspraxis" are "Drug" (14 trials), "Biological" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Obinutuzumab" (5 trials), "Cyclophosphamide" (4 trials), "Bendamustine" (3 trials), "Rituximab" (3 trials) and "Cetuximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Onkologische Gemeinschaftspraxis" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Onkologische Gemeinschaftspraxis". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Onkologische Gemeinschaftspraxis, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Onkologische Gemeinschaftspraxis, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".